Data as of Q4 2025 (Dec 31, 2025)

RNA

(RNA)

Financial Statements · SEC EDGAR XBRL

Revenue
$10.9M
+14.0%
Net Income
-$322.3M
-51.9%
Op. Income
-$378.9M
-60.8%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Operating Income
Non-Operating Income/Expense
Net Income
EPS (Basic)
EPS (Diluted)
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
$10.9M
$9.6M
-
$9.3M
$6.8M
$10.9M
$9.6M
-
$9.3M
$6.8M
-$378.9M
-$235.6M
-$178.9M
-$118.1M
-$44.3M
-$322.3M
-$212.2M
-$174.0M
-$118.0M
-$44.4M
-
-
$-3.34
-
-
-
-
$-3.34
-
-